We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cancer Cell Biology: Mutated KRAS & Reciprocal Signaling

Video   Sep 06, 2018 | Taken from The ICR London, YouTube


Across a wide variety of cancer types, a protein called KRAS can get hyperactivated and transmit an overload of unwanted growth signals to the cells, causing them to divide and form a tumor.

A tumor doesn't just contain cancer cells, though. It also has some non-cancer cells in there, such as immune cells and fibroblasts (cells that make the dense support structure that keeps cells stuck together).

Research by Chris Tape, Claus Jørgensen and colleagues at The Institute of Cancer Research, London, MIT, the Cancer Research UK Manchester Institute and The University of Manchester, has shed some new light on how mutated KRAS causes cancer cells to grow by promoting three distinct ways of cellular signaling:

  • Through a direct signaling pathway within the cancer cell, with KRAS signaling through the classic RAS-RAF-MEK-ERK signal transduction cascade, this is called cell-autonomous signaling.
  • By inducing the cancer cell to release a protein called SHH, which is able to start specific signaling pathways inside the fibroblast cells. This is called non-cell-autonomous signalling.
  • When these non-cell-autonomous signaling pathways in the fibroblast cells are induced, the fibroblasts are able to release growth factors that go back to the cancer cell, where they initiate more growth signaling pathways through a PI3K-AKT signal transduction cascade.

Uncovering these new ways in which mutated KRAS is able to promote cancer cell growth by hijacking fibroblast cell signaling could lead to new possibilities for therapeutic intervention.

This video was originally published by Phospho Biomedical Animation on 14/04/16 here.  

This content has been adapted from materials provided by The ICR London. Note: material may have been edited for length and content. For further information, please contact the cited source.

More Information

Recommended Videos

Cell Fates - Division, Senescence and Death


In this video, learn about the fates of a cell.


A "Living Drug" That Could Change the Way We Treat Cancer


In a talk about a breakthrough, CAR T-cell therapy pioneer, Carl June shares how three decades of research culminated in a therapy that's eradicated cases of leukemia once thought to be incurable – and explains how it could be used to fight other types of cancer.


CAR T-cell Therapy: Reprogramming the Immune System To Treat Cancer


Researchers are developing third generation CAR-T immunotherapy treatments which aim to be more effective with less side effects than previous therapies.



Like what you just watched? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free